Bayer
OpenCalais Metadata: Ticker: 
BAYG
  • Big Pharma struggles with the rise of generics
    Sales to emerging markets have been seen as buying time for the industry to reinvent itself beyond consolidation into ever-larger companies and share buy-backs. Asia-Pacific,Bayer,Big Pharma,Cipla,Generic drug,Nexavar,Novartis,pharmaceutical multinationals,public healthcare,USD,Paul Maidment